BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Veru
VERU
$46M
| $16.5K | ﹤0.01% |
204
-482
| -70% | -$42.4K |
|
|
LNAI
3452
Lunai Bioworks
LNAI
$10.2M
| $16.3K | ﹤0.01% |
41
-28
| -41% | -$9.12K |
|
|
DRRX
3453
DELISTED
DURECT Corp
DRRX
| $16.3K | ﹤0.01% |
1,001
-1,874
| -65% | -$32.7K |
|
|
CODX
3454
Co-Diagnostics
CODX
$5.49M
| $16.3K | ﹤0.01% |
66
-64
| -49% | -$16.5K |
|
3455
Graham Corp
GHM
$1.3B
| $16.2K | ﹤0.01% |
1,174
-4,005
| -77% | -$56.9K |
|
3456
BlueLinx
BXC
$705M
| $16.1K | ﹤0.01% |
+321
| New | +$15.8K |
|
|
ICBK
3457
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $16.1K | ﹤0.01% |
475
-1,820
| -79% | -$45.8K |
|
|
IIN
3458
DELISTED
IntriCon Corporation
IIN
| $16.1K | ﹤0.01% |
717
-3,263
| -82% | -$75.8K |
|
3459
Clearfield
CLFD
$390M
| $16.1K | ﹤0.01% |
430
-1,037
| -71% | -$36.8K |
|
|
AGFS
3460
DELISTED
AgroFresh Solutions Inc
AGFS
| $16.1K | ﹤0.01% |
7,742
-8,922
| -54% | -$19.2K |
|
|
CURO
3461
DELISTED
CURO Group Holdings Corp.
CURO
| $16.1K | ﹤0.01% |
945
-1,434
| -60% | -$22.3K |
|
|
CMBM
3462
DELISTED
Cambium Networks
CMBM
| $16K | ﹤0.01% |
331
-712
| -68% | -$38K |
|
|
APLT
3463
DELISTED
Applied Therapeutics
APLT
| $16K | ﹤0.01% |
768
-1,249
| -62% | -$23.6K |
|
|
LCI
3464
DELISTED
Lannett Company, Inc.
LCI
| $15.9K | ﹤0.01% |
853
-3,138
| -79% | -$60.2K |
|
|
EARN
3465
Ellington Residential Mortgage REIT
EARN
$167M
| $15.9K | ﹤0.01% |
1,350
-3,751
| -74% | -$46.4K |
|
|
FLNT
3466
Fluent
FLNT
$132M
| $15.8K | ﹤0.01% |
899
-2,355
| -72% | -$46.5K |
|
3467
Willdan Group
WLDN
$1.29B
| $15.8K | ﹤0.01% |
420
-1,996
| -83% | -$77.1K |
|
|
ORGS
3468
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $15.8K | ﹤0.01% |
312
-338
| -52% | -$17K |
|
|
AXIA
3469
DELISTED
AXIA Energia
AXIA
| $15.7K | ﹤0.01% |
2,298
| – | – |
|
3470
IES Holdings
IESC
$14.9B
| $15.7K | ﹤0.01% |
306
-2,371
| -89% | -$123K |
|
3471
Eagle Bancorp Montana
EBMT
$189M
| $15.7K | ﹤0.01% |
681
-2,552
| -79% | -$60.6K |
|
3472
TherapeuticsMD
TXMD
$24.1M
| $15.6K | ﹤0.01% |
263
-870
| -77% | -$52.7K |
|
3473
NVE Corp
NVEC
$563M
| $15.6K | ﹤0.01% |
211
-583
| -73% | -$41.5K |
|
|
ATNX
3474
DELISTED
Athenex, Inc. Common Stock
ATNX
| $15.4K | ﹤0.01% |
167
-4,276
| -96% | -$389K |
|
3475
LSI Industries
LYTS
$912M
| $15.4K | ﹤0.01% |
1,927
-11,111
| -85% | -$93.3K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.